Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells-Reference-Cited by-同舟云学术

Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells

Published:2014-05-04 Issue:12 Volume:5 Page:4180-4194
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Qian Wei¹,Wang Jingnan²,Roginskaya Vera¹,McDermott Lee A.³,Edwards Robert P.⁴,Stolz Donna B.⁵,Llambi Fabien⁶,Green Douglas R.⁶,Houten Bennett Van¹

Affiliation:

1. Department of Pharmacology & Chemical Biology, School of Medicine, University of Pittsburgh and Hillman Cancer Center, University of Pittsburgh Cancer Institute, Pittsburgh, PA 15213, USA

2. Tsinghua University School of Medicine, Tsinghua University, Haidian District, Beijing 100084, China

3. Department of Pharmaceutical Sciences, School of Pharmacy, University of Pittsburgh and University of Pittsburgh Drug Discovery Institute, Pittsburgh, PA 15213, USA

4. Department of Obstetrics & Gynecology, University of Pittsburgh Medical Center, Pittsburgh, PA 15213, USA

5. Department of Cell Biology, University of Pittsburgh, Pittsburgh, PA 15261, USA

6. Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insight into mitochondrial dynamin-related protein-1 as a new chemo-sensitizing target in resistant cancer cells;Bioorganic Chemistry;2024-09

2. Mitochondria in Lung Cancer Progression;Current Pharmacology Reports;2024-08-27

3. Molecular Modulators and Receptors of Selective Autophagy: Disease Implication and Identification Strategies;International Journal of Biological Sciences;2024

4. Mitochondria act as a key regulatory factor in cancer progression: Current concepts on mutations, mitochondrial dynamics, and therapeutic approach;Mutation Research - Reviews in Mutation Research;2024-01

5. Srf/Slc31a1 Signaling Promotes Cuproptosis Induced by Celastrol in Nsclc;2024